全文获取类型
收费全文 | 129707篇 |
免费 | 4462篇 |
国内免费 | 843篇 |
出版年
2021年 | 414篇 |
2019年 | 383篇 |
2018年 | 12154篇 |
2017年 | 10980篇 |
2016年 | 7996篇 |
2015年 | 1401篇 |
2014年 | 1175篇 |
2013年 | 1604篇 |
2012年 | 5518篇 |
2011年 | 14055篇 |
2010年 | 12792篇 |
2009年 | 8933篇 |
2008年 | 10765篇 |
2007年 | 12362篇 |
2006年 | 1292篇 |
2005年 | 1455篇 |
2004年 | 1847篇 |
2003年 | 1925篇 |
2002年 | 1657篇 |
2001年 | 2213篇 |
2000年 | 2088篇 |
1999年 | 1540篇 |
1998年 | 552篇 |
1997年 | 538篇 |
1996年 | 529篇 |
1995年 | 455篇 |
1994年 | 457篇 |
1993年 | 471篇 |
1992年 | 1117篇 |
1991年 | 1146篇 |
1990年 | 1098篇 |
1989年 | 1059篇 |
1988年 | 991篇 |
1987年 | 929篇 |
1986年 | 790篇 |
1985年 | 761篇 |
1984年 | 608篇 |
1983年 | 541篇 |
1982年 | 379篇 |
1981年 | 358篇 |
1980年 | 341篇 |
1979年 | 577篇 |
1978年 | 453篇 |
1977年 | 419篇 |
1976年 | 342篇 |
1975年 | 469篇 |
1974年 | 478篇 |
1973年 | 421篇 |
1972年 | 644篇 |
1971年 | 586篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
11.
12.
13.
14.
Background
Recent studies point to a great diversity of non-ribosomal peptide synthesis systems with major roles in amino acid and co-factor biosynthesis, secondary metabolism, and post-translational modifications of proteins by peptide tags. The least studied of these systems are those utilizing tRNAs or aminoacyl-tRNA synthetases (AAtRS) in non-ribosomal peptide ligation. 相似文献15.
16.
Minh C. Nguyen Guang Huan Tu Kathryn E. Koprivnikar Melissa Gonzalez-Edick Karin U. Jooss Thomas C. Harding 《Cancer immunology, immunotherapy : CII》2010,59(9):1313-1323
A critical factor in clinical development of cancer immunotherapies is the identification of tumor-associated antigens that
may be related to immunotherapy potency. In this study, protein microarrays containing >8,000 human proteins were screened
with serum from prostate cancer patients (N = 13) before and after treatment with a granulocyte–macrophage colony-stimulating factor (GM-CSF)-secreting whole cell immunotherapy.
Thirty-three proteins were identified that displayed significantly elevated (P ≤ 0.05) signals in post-treatment samples, including three proteins that have previously been associated with prostate carcinogenesis,
galectin-8, T-cell alternative reading frame protein (TARP) and TNF-receptor-associated protein 1 (TRAP1). Expanded analysis
of antibody induction in metastatic, castration-resistant prostate cancer (mCRPC) patients (N = 92) from two phase 1/2 trials of prostate cancer immunotherapy, G-9803 and G-0010, indicated a significant (P = 0.03) association of TARP antibody induction and median survival time (MST). Antibody induction to TARP was also significantly
correlated (P = 0.036) with an increase in prostate-specific antigen doubling time (PSADT) in patients with a biochemical (PSA) recurrence
following prostatectomy or radiation therapy (N = 19) from in a previous phase 1/2 trial of prostate cancer immunotherapy, G-9802. RNA and protein encoding TARP and TRAP1
was up-regulated in prostate cancer tissue compared to matched normal controls. These preliminary findings suggest that antibody
induction to TARP may represent a possible biomarker for treatment response to GM-CSF secreting cellular immunotherapy in
prostate cancer patients and demonstrates the utility of using protein microarrays for the high-throughput screening of patient-derived
antibody responses. 相似文献
17.
18.
19.